1. Home
  2. DTSS vs PHIO Comparison

DTSS vs PHIO Comparison

Compare DTSS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$1.10

Market Cap

10.9M

Sector

Technology

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.20

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTSS
PHIO
Founded
2014
2011
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
12.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DTSS
PHIO
Price
$1.10
$1.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
129.4K
8.4M
Earning Date
02-11-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$64,349,277.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
68.56
N/A
52 Week Low
$0.64
$0.81
52 Week High
$2.89
$4.19

Technical Indicators

Market Signals
Indicator
DTSS
PHIO
Relative Strength Index (RSI) 51.36 60.85
Support Level $0.82 $0.81
Resistance Level $1.15 $1.48
Average True Range (ATR) 0.17 0.09
MACD -0.00 0.02
Stochastic Oscillator 33.68 58.04

Price Performance

Historical Comparison
DTSS
PHIO

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: